Wrestling with the High Price of Cancer Care

Should We Control Costs By Individuals' Ability to Pay or Society's Willingness to Pay?

Published In: Journal of Clinical Oncology, v. 28, no. 20, Editorial, July 10, 2010, p. 3212-3214

by Jennifer Malin

Read More

Access further information on this document at the publisher's website

This article was published outside of RAND. The full text of the article can be found at the link above.

Rising costs of cancer treatment raise questions about how to ensure that patients receive access to the best therapy that is a "good value" - both from the perspective of the patient and all who pay for health care (i.e., through taxes, insurance).

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/research-integrity.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.